FAM
TWST icon

Fred Alger Management’s Twist Bioscience TWST Stock Holding History

Fred Alger Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-64,000
Closed -$2.25M – 569
2022
Q3 		$2.25M Buy
+64,000
New +$2.72M 0.01% 330

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Fred Alger Management's TWST Position: Q2 2026 in Review

Fred Alger Management increased its Twist Bioscience (TWST) stake by 483% in Q2 2026, buying an estimated $30.1M and bringing the position to 558,157 shares worth $57.4M. The position accounts for 0.19% of the portfolio, ranked #63.

Fred Alger Management first reported a position in TWST in Q2 2019 and has held it in 20 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Fred Alger Management held 558,157 shares of Twist Bioscience worth $57.4M as of Q2 2026.
  • Fred Alger Management bought 462,374 Twist Bioscience shares in Q2 2026, an estimated $30.1M.
  • Twist Bioscience made up 0.19% of Fred Alger Management's portfolio in Q2 2026, its #63 holding.
  • Fred Alger Management first reported a position in Twist Bioscience in Q2 2019 and has held it in 20 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.